Share on facebook
Share on twitter
Share on linkedin

September, 2015: Plasma Gelsolin Patent Portfolio Further Expands Coverage in Asia

Patents Granted for Renal Failure in Japan and Inflammation in Korea

BOSTON MASSACHUSSETTS and MORRISTOWN, NEW JERSEY–(BIOAEGIS THERAPEUTICS – September, 2015) BioAegis Therapeutics announced today patents were recently granted covering plasma gelsolin uses for renal failure in Japan and inflammation in Korea. Further applications in jurisdictions in Asia are also pending.